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Background: Previous molecular characterizations of mammary stem cells (MaSC) have
utilized fluorescence-activated cell sorting or in vitro cultivation of cells from enzymatically
dissociated tissue to enrich for MaSC. These approaches result in the loss of all histologi-
cal information pertaining to the in vivo locale of MaSC and progenitor cells. Instead, we
used laser microdissection to excise putative progenitor cells and control cells from their
in situ locations in cryosections and characterized the molecular properties of these cells.
MaSC/progenitor cells were identified based on their ability to retain bromodeoxyuridine
for an extended period.
Results: We isolated four categories of cells from mammary epithelium of female calves:
bromodeoxyuridine label retaining epithelial cells (LREC) from basal (LRECb) and embed-
ded layers (LRECe), and epithelial control cells from basal and embedded layers. Enriched
expression of genes in LRECb was associated with stem cell attributes and identifiedWNT,
TGF-β, and MAPK pathways of self renewal and proliferation. Genes expressed in LRECe
revealed retention of some stem-like properties along with up-regulation of differentiation
factors.
Conclusion: Our data suggest that LREC in the basal epithelial layer are enriched for MaSC,
as these cells showed increased expression of genes that reflect stem cell attributes;
whereas LREC in suprabasal epithelial layers are enriched for more committed progenitor
cells, expressing some genes that are associated with stem cell attributes along with those
indicative of cell differentiation. Our results support the use of DNA label retention to iden-
tify MaSC and also provide a molecular profile and novel candidate markers for these cells.
Insights into the biology of stem cells will be gained by confirmation and characterization
of candidate MaSC markers identified in this study.
Keywords: label retention, mammary stem cells, mammary progenitor cells, stem cell markers, laser
microdissection
INTRODUCTION
In female mammals, growth and development of mammary
glands occur primarily postnatally, with mammary function in
the mature animal being tightly coupled to reproductive strategy.
This dictates cycles of mammary growth, differentiation, lactation,
and regression, during which mammary stem cells (MaSC) pro-
vide for the lineages of luminal and basal (myoepithelial) epithelial
cells in the ducts and alveoli. Although mice have provided the
primary model for study of mammary growth and development,
a single model species cannot provide comprehensive knowledge.
Because mammary glands of prepubertal calves have a tissue archi-
tecture resembling that of the prepubertal human breast more
closely than does mouse (Capuco et al., 2002), cows provide an
additional experimental model for human breast development.
Increased knowledge of MaSC is directly applicable to agriculture
and the development of management schemes to enhance the
lifetime productivity of dairy cows and other species.
A method that has been used to identify MaSC is based upon the
capacity of these cells to retain 5-bromo-2′-deoxyuridine (BrdU)
labeled DNA for an extended period (Kenney et al., 2001; Welm
et al., 2002; Smith, 2005; Capuco, 2007). Retention of labeled DNA
strands may be attributed to the ability of stem cells to retain
the parental DNA strand during asymmetric cell division (Cairns,
1975) or to quiescence of the stem cell population such that the
DNA label is not diluted by frequent cell divisions (Klein and
Simons, 2011). During rapid mammary growth in the mouse,
label retaining epithelial cells (LREC) appear to retain label by
asymmetric distribution of DNA strands, as evidenced by a rapid
proliferation index of the LREC (Smith, 2005). During peri-
ods of low mammary proliferation, quiescence of the stem cell
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population may account for retention of label. LREC are enriched
in populations that exhibit MaSC capacity, i.e., the ability to regen-
erate mammary epithelium upon transplantation into the cleared
mammary fat pad of syngeneic mice (Welm et al., 2002).
We previously reported that LREC in mammary epithelium of
calves were localized in the basal layer (LRECb) and in the embed-
ded (LRECe) layers between the basal and luminal cells of a multi-
layered epithelium (Capuco, 2007; Capuco et al., 2009). The LREC
in bovine mammary gland appeared to have a modest proliferation
rate in which 5.4% of LREC co-expressed Ki-67 (Capuco, 2007).
LRECb were estrogen receptor-α (ESR1) -negative and hypothe-
sized to be MaSC, whereas the LRECe were a mixed population
of ESR1-positive and -negative cells that were hypothesized to be
progenitor cells (Capuco, 2007; Capuco et al., 2009). The estro-
gen receptor status of MaSC is of considerable interest because of
the importance of estrogens for MaSC function, mammary duc-
tal growth, and tumorigenesis. MaSC of mouse and human are
ESR1-negative (Anderson and Clarke, 2004; Asselin-Labat et al.,
2006; Sleeman et al., 2007; Lamarca and Rosen, 2008).
Morphological evidence suggests that MaSC are basally local-
ized within the mammary epithelium, typically underlain by cyto-
plasmic extensions of epithelial cells and in close proximity to
ESR1-positive epithelial cells (Smith and Chepko, 2001; Brisken
and Duss, 2007). However, MaSC have not been fully characterized
due to technical limitations inherent in stem cell identification and
in isolation of cells from known locations within the mammary
epithelium. Based on fluorescence-activated cell sorting with mul-
tiple biomarkers and use of mammary transplantation methods to
evaluate multi-lineage potency, Shackleton, Stingl, and colleagues
obtained and characterized a population of cells, from enzymat-
ically dispersed mammary tissue, that was enriched for MaSC
(Shackleton et al., 2006; Stingl et al., 2006). Critical to the success of
this pioneering approach was use of markers to deplete the popu-
lation of hematopoietic (CD45 and TER119) and endothelial cells
(CD31), as well as markers to select epithelial cells (CD29, CD49f),
likely from a basal location, that expressed heat stable antigen
(CD24). Another approach utilized for enrichment and character-
ization of human MaSC involved characterization of mammary
epithelial cells that possess multipotency potential in vitro (Dontu
et al., 2003).
Cell sorting techniques have also been applied to suspensions
of bovine mammary cells in an attempt to enrich for MaSC. Motyl
et al. (2011) isolated and evaluated gene expression in a popula-
tion of mammary cells that were isolated on the basis of SCA1
expression and showed up-regulation of genes that are charac-
teristic of hematopoietic cells. However, because accompanying
micrographs clearly show that most SCA1-positive cells were in the
mammary stroma and methods to enrich for mammary epithelial
cells were not employed, the gene expression profile likely cannot
be attributed to MaSC. Furthermore, previous research indicates
the likelihood of hematopoietic cells populating the mammary
stem cell niche is highly unlikely (Niku et al., 2004). Research by
Martignani et al. (2010) utilized aldehyde dehydrogenase (ALDH)
activity as a selection criterion for cell sorting and demonstrated
that cells with low ALDH activity were capable of regenerating
functional structures of mammary epithelium within collagen gels
implanted beneath the kidney capsule of immunodeficient mice.
This latter study not only provides data pertaining to character-
istics of bovine bipotent progenitor cells, but validates a means
to assess such potency. Most recently, Rauner and Barash (2012)
used the multiparameter cell sorting technique developed for
enrichment of murine MaSC (Shackleton et al., 2006) to obtain
and characterize four populations of mammary epithelial cells
from dissociated bovine mammary gland. The differentiation and
growth potential of the cells were assessed by in vitro colony forma-
tion and mammosphere assays. This study confirmed many of the
general aspects of MaSC/progenitor cells evident in mouse and
human studies. The four populations included putative bovine
MaSC (CD24medCD49fpos) that were bipotent (myoepithelial and
luminal) and possessed a high growth rate; basal bipotent progeni-
tors with medium growth rate and low sphere generating potential;
luminal unipotent progenitors with low growth rate; and luminal
unipotent cells with very limited proliferative activity. Although
putative MaSC typically possessed little or no ALDH activity,
as reported previously (Martignani et al., 2010), 0.4% of total
viable cells expressed high ALDH activity, which they hypothesized
represent the MaSC population.
In addition to issues pertaining to the isolation of MaSC from a
mixed suspension of mammary cells, all previous studies have eval-
uated MaSC after removing them from their stem cell niche, i.e.,
the microenvironment of surrounding signaling molecules and
other non-cellular components that support stem cell function
and survival. We have taken an approach that retains histological
information by characterizing gene expression in putative MaSC
directly after their in situ excision from the mammary epithelium.
The histological location of all cells interrogated was known.
In the present study, putative stem and progenitor cells (LREC)
were identified and excised from cryosections using laser microdis-
section. It must be recognized that identification of putative MaSC
and progenitor cells on the basis of long-term retention of DNA
label is to select the cells based upon their life-history (i.e., the
extent of label retention represents an integration of the cell’s
past proliferation and differentiation events). Consequently, one
would anticipate that selecting putative MaSC and progenitor cells
based on label retention is likely to represent enrichment for these
cell populations. In this study, LREC and neighboring epithelial
control (non-LREC) cells were excised from two different loca-
tions: basal and embedded layers of the mammary epithelium.
We hypothesized that LRECb are enriched for MaSC whereas
LRECe are enriched for more committed progenitor cells, and that
by comparing the transcriptomes of these cells with neighboring
control cells we would obtain molecular profiles and biomarkers
for MaSC and progenitor cells. Results are consistent with these
hypotheses and provide novel candidate markers for MaSC and
progenitor cells.
MATERIALS AND METHODS
EXPERIMENTAL ANIMALS AND MAMMARY TISSUE
Use of animals for this study was approved by the Beltsville
Agricultural Research Center’s Animal Care and Use Committee.
Tissues for this study were obtained from five Holstein heifers
at approximately 5 months of age (4.8± 0.05, mean± SE). At
approximately 3 months of age, heifers were injected intravenously
with BrdU (Sigma-Aldrich Co., St. Louis, MO, USA) for five
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consecutive days. BrdU was administered in a saline solution
containing 20 mg BrdU/ml (0.9% sodium chloride; pH 8.2) at a
dosage of 5 mg/kg body weight, as described previously (Capuco,
2007). Heifers were sacrificed humanely at the Beltsville Agricul-
tural Research Center abattoir 45 days after the last BrdU injection.
Mammary tissue (∼5 mm× 5 mm× 5 mm) was collected from
the outer parenchymal region (region in close proximity to the
border with mammary fat pad) of a rear mammary gland. Indi-
vidual samples were immediately embedded in OCT compound
(Sakura, Torrance, CA, USA), frozen in liquid nitrogen vapor and
stored at−80˚C until use.
Cryosections of 8µm thickness were thaw-mounted on
ultraviolet-irradiated PEN slides (Leica AS,Wetzlar, Germany) and
stored at −80˚C until BrdU immunostaining and laser microdis-
section within 8 days. Mammary tissues harvested for histological
validation of microarray data were fixed overnight in 10% neu-
tral buffered formalin at 4˚C and then stored in 70% ethanol
until further processing. Tissues were then dehydrated and embed-
ded in paraffin according to standard techniques and sectioned at
5µm thickness onto Superfrost-plus™ slides (Erie Scientific Co.,
Portsmouth, NH, USA).
BrdU IMMUNOSTAINING TO IDENTIFY PUTATIVE MaSC
Putative MaSC were identified as those cells in cryosections that
retained BrdU label (Figure 1D), visualized using an optimized
method for BrdU immunostaining that retains RNA quality in
tissue cryosections (Choudhary et al., 2010). Sections were indi-
vidually processed immediately before laser microdissection. The
cryosections were fixed in acetone/polyethylene glycol 300 (9:1
v/v) at−20˚C for 2 min and air dried for 1 min and then incubated
with 0.5% methyl green for 2 min at room temperature (RT). After
a brief wash (10 s) with nuclease-free phosphate buffered saline
(nfPBS), 400µl of a pre-warmed solution of 70% deionized for-
mamide in nfPBS was pipetted onto the tissue and the section
incubated at 60˚C for 4 min. The section was washed with anti-
body dilution buffer (nfPBS with 1% normal goat serum and 0.1%
triton-X 100) at 4˚C on a metal plate kept on ice to prevent re-
annealing of DNA strands and then incubated with mouse mono-
clonal anti-BrdU antibody conjugated to Alexa 488 (Clone PRB-1,
1:10 dilution, Molecular Probes, Carlsbad, CA, USA) for 5 min
at RT in the dark. The section was washed briefly before coun-
terstaining with propidium iodide (2.5µg/µl in nfPBS). Finally,
the slide was washed with nuclease-free water (10 s), dehydrated
in ascending concentrations of ethanol and air dried before laser
microdissection.
LASER MICRODISSECTION AND cDNA AMPLIFICATION
Immediately after staining, sections were examined and cells
excised with a laser microdissection system equipped for epifluo-
rescence microscopy (Leica AS-LMD, Mannheim, Germany). The
laser setting was determined empirically and dissection performed
using the 40× objective. We dissected 6–13 cells per category per
heifer. For each animal, cells in a given category were collected
into the cap of a 0.2 ml thin-walled PCR tube (Biozyme Scien-
tific GmbH, Hess Oldendorf, Germany). Total processing time
for immunostaining and microdissection was less than 1 h, and
only one slide was processed at a time. Four categories of cells
were dissected: LREC from basal (LRECb) and embedded layers
(LRECe), and epithelial control cells from basal (ECb) and embed-
ded layers (ECe). Cells within the cap were dissolved in 2µl of
lysis buffer (WT-Ovation™ One-Direct RNA Amplification Sys-
tem; NuGEN Technologies, Inc., San Carlos, CA, USA). The tube
was capped and centrifuged for 1 min at 14,000× g, after which
the tube and contents were vortexed gently for 30 s and centrifuged
briefly before placing on ice. First stand cDNA synthesis and
amplification reaction were carried out using Ribo-SPIA-based
methodology according to the manufacturer’s recommendations.
Concentrations of amplified cDNA were determined spectropho-
tometrically (ND-1000, NanoDrop Technologies, Rockland, DE,
USA). A known amount of high quality RNA (250 pg) was used as
positive control for cDNA amplification. Nuclease-free water was
used as a no-template control for cDNA amplification. The ampli-
fied cDNA was evaluated using RNA Nano-chips to estimate the
median fragment size (Agilent Technologies, Palo Alto, CA, USA).
Median fragment size for amplified samples was similar to the
positive control and fell within the expected range of 100–300 bp,
whereas products for the no-template control were <50 bp.
MICROARRAY ANALYSIS
Oligonucleotide microarray analysis was performed using a cus-
tom bovine microarray (Nimblegen, Inc., Madison, WI, USA)
as described previously (Li et al., 2006). The bovine microarray
consisted of 86,191 unique 60-mer oligonucleotides, representing
45,383 bovine sequences. The array design was based upon a TIGR
assembly (release 11.0 from 2004). However, all 60-mer oligonu-
cleotides on the array were annotated against current bovine
RefSeq databases as well as the latest version of ENSEMBL bovine
gene build v65.0 (released on December 20111). After hybridiza-
tion, scanning, and image acquisition, the data were extracted
from the raw images using NimbleScan software (NimbleGen).
A total of 21 microarrays (five animals× four categories of cells,
and no-template amplification control) were used. Relative signal
intensities (log2) for each feature were generated using the robust
multi-array average algorithm (Irizarry et al., 2003) and data were
processed based on the quantile normalization method (Bolstad
et al., 2003). Only oligos that provided hybridization signal inten-
sities for samples that exceeded 3× the signal intensity obtained
with the no-template amplification control (water blank) were
included in the analysis. Furthermore, only sample signal inten-
sities exceeding twice the array background intensity (mean of
lowest 3% of oligo intensities) were considered for analysis.
P values were calculated using a modified t -test. Fold changes
were calculated as the ratio of the means of background-adjusted,
normalized fluorescent intensity of cells of interest to their respec-
tive controls. Group-wise comparisons were performed in accor-
dance with recommendations of the Microarray Quality Control
project (Shi et al., 2006, 2008) based on t -test (P < 0.05) followed
by fold change (twofold as a cutoff) to determine significance.
These criteria were shown to achieve a balance of reproducibil-
ity, sensitivity, and specificity, using single or multiple microarray
platforms (Shi et al., 2006, 2008; Chin et al., 2009, 2010; Wang
1http://uswest.ensembl.org/downloads.html
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et al., 2011). Based upon these criteria, genes that were differ-
entially expressed were then subjected to pathway analysis (IPA,
Ingenuity Systems2).
The microarray data discussed in this publication have been
deposited in NCBI’s Gene Expression Omnibus (Edgar et al.,
2002) and are accessible through GEO Series accession number
GSE315413.
REALTIME QUANTITATIVE RT-PCR
Realtime quantitative RT-PCR (qRT-PCR) was performed using
aliquots of amplified cDNA from all animals and an IQ SYBR
Green Supermix kit (Bio-Rad Laboratories, Hercules, CA, USA).
Each reaction was performed in a 25µl reaction volume contain-
ing 200 nM of each amplification primer and 2 ng of cDNA. The
amplification was performed in a Bio-Rad iCycler using the fol-
lowing protocol: 95˚C – 60 s; 45 cycles of 94˚C – 15 s, 61˚C – 30 s,
and 72˚C – 30 s. A melting curve analysis was performed for each
primer pair. Standards were prepared from PCR amplicons puri-
fied using the QIAquick purification kit (Qiagen Inc.,Valencia, CA,
USA). Product concentrations were determined using the Agilent
2100 BioAnalyzer and DNA 500 kits (Agilent Technologies) and
diluted to contain 1× 102 to 1× 108 molecules/µl. Quantity of
cDNA in unknown samples was calculated from the appropriate
external standard curve run simultaneously with samples.
IMMUNOHISTOCHEMISTRY
Paraffin sections were dewaxed in xylene and hydrated in a graded
series of ethanol to phosphate buffered saline (PBS, pH 7.4). Tis-
sue sections were quenched with 3% H2O2 in PBS for 10 min
and then washed in PBS. Antigen retrieval was performed by
incubation with 70% formamide in PBS at 60˚C for 5 min, or
microwave heating in 10 mM Tris containing 1 mM EDTA, pH
9.0 (5 min heat, 5 min rest, 5 min heat, 25 min cooling). Sections
were blocked with casein (CAS-block™, Invitrogen, Carlsbad,
CA, USA). Primary antibodies NR5A2, NUP153, and HNF4A
(Abcam Inc., Cambridge, MA, USA) were used at 1:200 dilu-
tion and FNDC3B (Santa Cruz, Santa Cruz, CA, USA) at 1:50.
Sections were incubated with primary antibody for 2 h at RT
or overnight at 4˚C. After washing in PBS, sections were incu-
bated with horseradish peroxidase-conjugated broad spectrum
secondary antibody (ImmPRESS anti-mouse/anti-rabbit, Vector
Labs, Burlingame, CA, USA). Positively labeled cells were visual-
ized brown or purple using 3,3′-diaminobenzidine or ImmPACT
VIP (Vector Labs), respectively. Slides were washed and then
counterstained with hematoxylin or methyl green.
To determine if cells expressing FNDC3B were LREC, dual
antigen labeling was performed. Tissue sections were processed
as described earlier and incubated with mouse monoclonal BrdU
antibody (Clone BMC 9318, 2µg/ml; Roche Diagnostics Corp.,
Indianapolis, IN, USA) for 2 h at RT. Sections were then incubated
with vector ImmPRESS anti-mouse polymer detection reagent
(Vector Labs) for 20 min, followed by washing in PBS. BrdU
was detected by incubation for 10 min with the chromagen 3,3′-
diaminobenzidine. Sections were then washed in deionized water.
2www.ingenuity.com
3http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31541.
Peroxidase activity was quenched for a second time with 3%
H2O2 in PBS, followed by washings with water. Sections were
blocked with casein and then incubated overnight at 4˚C with
FNDC3B rabbit polyclonal antibody (1:50 dilution), washed, and
then incubated with horseradish peroxidase-conjugated broad
spectrum secondary antibody. Sections were washed with PBS and
FNDC3B staining was visualized after incubation with a contrast
purple chromogen, ImmPACT™ VIP peroxidase substrate (Vec-
tor Labs). Sections were washed in deionized water, counterstained
with 0.5% aqueous methyl green (Vector Labs), differentiated in
0.05% acetic acid/acetone, washed dehydrated in ethanol, cleared
in xylene, and mounted in DPX (Sigma). Omission of primary
antibodies was used for negative controls.
Immunofluorescence staining was performed, as described pre-
viously (Capuco, 2007), to determine the ESR1 status of LREC by
assessing the co-localization of BrdU and ESR1.
RESULTS
IDENTIFICATION OF LREC IN THE TERMINAL DUCTULAR UNITS OF
BOVINE MAMMARY GLAND
During the period of ductal morphogenesis, the prepubertal mam-
mary gland grows allometrically and mammary ducts expand into
the surrounding mammary fat pad (Capuco et al., 2002; Meyer
et al., 2006). The terminal ductular units of the prepubertal mam-
mary gland, which are prevalent at this time, are arborescent
structures composed of a multilayered epithelium (Capuco et al.,
2002; Figures 1A,B). One approach, which we have utilized, to
identify putative stem cells is based on the observation that somatic
stem cells often retain labeled DNA strands for a prolonged period
after initial labeling with tritiated thymidine or BrdU (Potten et al.,
1978; Bickenbach, 1981). In mice, intestinal crypt cells (Potten
et al., 2002), muscle satellite cells (Conboy et al., 2007), and puta-
tive MaSC (Welm et al., 2002; Smith, 2005) retain labeled DNA.
Although long-term retention of BrdU does not appear to be a uni-
versal marker for somatic stem cells, it appears to provide a means
for identifying putative stem/progenitor cells in mammary gland.
After staining BrdU-labeled cells in cryosections without com-
promising RNA quality (Choudhary et al., 2010), we employed
laser microdissection to collect LREC from basal and embedded
layers of the mammary epithelium, along with appropriate con-
trol cells (Figures 1C,D). The transcriptome of these cells was
interrogated by microarray analysis, from which we based our
characterization of these interesting LREC in bovine mammary
gland.
TRANSCRIPTOMES OF LRECb vs. ECb
To evaluate the hypothetical stem cell nature of LRECb, we com-
pared the transcript profiles of LRECb vs. neighboring control cells
(ECb). This analysis identified 605 genes that were differentially
expressed between these two cell types (Table S1 in Supplemen-
tary Material). Of these, 476 corresponded to genes that were
functionally annotated in the Ingenuity Pathway Analysis data-
base. Differentially expressed genes were involved in pathways
linked to cancer, gene expression, cell growth and proliferation,
and cell death (Table S2 in Supplementary Material). A num-
ber of genes with documented relevance to MaSC were identified
in this analysis (Tables 1 and 2). Low expression of ESR1 and
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FIGURE 1 | Characteristics and dissection of the mammary epithelium of
a prepubertal heifer. (A,B) Micrographs of the terminal ductular units of a
prepubertal bovine mammary gland illustrating the arborescent nature of
these terminal ducts and their multilayered epithelium. (C) Diagrammatic
representation of the mammary epithelium illustrating the four classes of
cells dissected. BM, basement membrane. (D) Micrograph of cryosections
stained for BrdU antigen prior to laser microdissection, localization of LRECb
and LRECe are depicted. (E) Micrograph of epithelium of terminal ductular
unit stained for KRT19. The basal layer consists of cells that are predominantly
KRT19-negative.
high expression of ALDH 3B1 (ALDH3B1) in LRECb were con-
sistent with MaSC character. Similar to the situation in mouse
and human, putative bovine MaSC (LRECb) appear to be ESR1-
negative (Capuco et al., 2009; Figures 7E,F), and increased ALDH
activity is consistent with MaSC/progenitor character (Douville
et al., 2009; Martignani et al., 2010; Rauner and Barash, 2012).
Increased abundance of HNF4A, NR5A2, NES, TERF1, NUP153,
and FNDC3B mRNA and decreased abundance of X-chromosome
inactivation factor (XIST ) in LRECb are noteworthy (Table 1 and
Table S1 in Supplementary Material). Hepatocyte nuclear factor
(HNF4A) is a liver stem cell transcription factor (Battle et al.,
2006; Delaforest et al., 2011), NR5A2 is a pluripotency transcrip-
tion factor analogous to OCT4 (Heng et al., 2010), Nestin (NES)
is a neural stem cell marker (Wiese et al., 2004), and TERF1
(Telomeric repeat binding factor 1) is a marker for human and
mouse embryonic stem cells (Ginis et al., 2004). FNDC3B has
been characterized as a marker of proliferation and cell migra-
tion. The absence or very low abundance of XIST, in LRECb is
consistent with MaSC identity, as absence of XIST expression
and low XIST expression have been associated with hematopoi-
etic stem and progenitor cells, respectively (Savarese et al., 2006).
Transcripts of several genes that are involved in epigenetic mod-
ification of chromatin were also enriched in LRECb. Relative to
ECb, LRECb expressed a greater number of transcription regula-
tors, zinc fingers, and nuclear transporters (e.g.,NUP153, IPO13).
Importin 13 (IPO13) is a nucleocytoplasmic transport protein,
which may serve as a marker for corneal epithelial progenitor
cells (Wang et al., 2009). Because elements of the nuclear pore
complex and importin are frequently down-regulated following
cell differentiation (Yasuhara et al., 2009), increased expression of
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NUP153 and IPO13 in LRECb suggests that LRECb are undiffer-
entiated epithelial cells. Recent research by Sherley and colleagues
was undertaken to discover biomarkers for distributed stem cells,
based upon identification of genes that are tightly coupled to
asymmetric self renewal of cells in culture (Noh et al., 2011).
Among the genes identified by these researchers, expression of
EPHX1,MTBP,COL11A1, and ARHGAP was increased in LRECb
in the current experiment. Finally, expression of cytokeratin mark-
ers was consistent with expression by MaSC. The basal epithelial
cells were KRT19-negative (Figure 1E), and transcriptome analy-
sis indicated that KRT5 was strongly down-regulated in LRECb,
consistent with MaSC (Petersen and Polyak, 2010). Transcripts
for fibroblast growth factors (FGF1, FGF2, FGF10), insulin-like
growth factor-2 (IGF2) and follistatin (FST) were also enriched in
LRECb. Overall, the gene expression profile of LRECb is consistent
with MaSC character (Tables 1 and 2).
Further evidence in support of the stem cell nature of LRECb
comes from biological pathway analysis of differentially expressed
genes. Ingenuity Pathway Analysis of genes that were differen-
tially expressed in LRECb and ECb revealed biological processes
and networks that were highly significant. (Significance of a bio-
logically relevant network of genes was expressed in IPA score,
which was derived from P-value and indicates likelihood of the
focused genes in a network being found together due to ran-
dom chance. The IPA score is expressed as the negative log
of the P-value.) The most significant networks associated with
LRECb related to cellular growth and proliferation (Figure 2A,
IPA score= 58), and cell cycle and post translational modifi-
cation (Figure 2B, IPA score= 34). The network of cellular
growth and proliferation (Figure 2A) contains a single mod-
ule with HNF4A, up-regulated in LRECb, as the hub. Down-
regulation of developmental genes like SIX2 and XIST suggests
that LRECb are undifferentiated cells. KEGG pathway analysis
using DAVID (Huang da et al., 2009) revealed that genes which
were differentially expressed in LRECb vs. ECb reflected up-
regulation of several pathways. These included the MAPK pathway
(FGF1, FGF2,FGF10,TAOK3,BRAF,ATF4,CREB,HSPA8,PDGFB,
CDC25B), a pathway involved in cellular growth and proliferation,
and the WNT (DVL2, PPP2R5E, SMAD4) and TGF-β (FST and
SMAD4) pathways, which are associated with stem cell renewal
(Esmailpour and Huang, 2008; Mazumdar et al., 2010). In con-
trast to other members of the WNT pathway,HOXA9 was strongly
down-regulated in LRECb.
TRANSCRIPTOMES OF LRECe VS. ECe
Comparison of transcriptome profiles of LRECe and neigh-
boring ECe identified 101 functionally annotated genes that
were differentially expressed (Table S1 in Supplementary Mate-
rial) and supports classification of LRECe as progenitor cells
(Table 1). The most significant network associated with these
genes was related to cancer (Figure 3A, IPA score= 51), fol-
lowed by a network associated with DNA replication, recom-
bination and repair (Figure 3B, IPA score= 36) that con-
tained a HNF4A module. Conservation of the HNF4A mod-
ule in LRECe and LRECb suggests a hierarchical similarity
between LRECe and LRECb; although HNF4A transcripts were
not significantly up-regulated in LRECe and genes involved
in this module differed between the two categories of LREC.
Enriched expression of NR5A2 and FNDC3B in both LRECe
and LRECb (vs. ECe and ECb, respectively) provides another
line of evidence for the similarity of LREC in basal and embed-
ded epithelial layers. KEGG pathway analysis (DAVID) of tran-
scripts that were up-regulated in LRECe vs. ECe identified up-
regulation of the WNT pathway (DVL3, ADCY6, CAMK2D)
and down-regulation of an inhibitor of the WNT pathway,
(CAMK2N1).
TRANSCRIPTOMES OF LRECb VS. LRECe
To evaluate the relative characteristics of LRECb and LRECe,
transcript profiles for these cells were compared. We identified
269 genes that were differentially expressed in LRECb vs. LRECe
(Table S1 in Supplementary Material). Relatively high expression
of stem cell markers, growth, and survival factors, DNA repair
enzymes and low expression of apoptotic genes and differentia-
tion markers supported greater “stemness” of LRECb vs. LRECe
(Tables 1–3). The molecular profile of LRECb included increased
abundance of transcripts for stem cell markers (NR5A2, NES,
THY1), as well as cell survival and proliferation factors (IGF2,
FGF2, FGF10, HSPB6, LAMC1, CSF3, FST, IL33, MESDC2, AGT ).
Additionally, enriched expression of cell adhesion molecules
(CADM3, NCAM1, AOC3), and a number of cell surface mark-
ers (ANXA6, CCR1, CCR4, CXCR4, DRD2, GNB4, GRB14, SAT2,
SDPR, THY1/CD90, TRIB2) were noted in LRECb. THY1 has
been used as a marker for hematopoietic progenitor cells (Gold-
schneider et al., 1978; Craig et al., 1993), mesenchymal stem cells
(Gargett et al., 2009), and mammary cancer stem cells (Diehn et al.,
2009). The LRECe displayed increased expression of XIST, splicing
factor arginine/serine-rich 5 (SFRS5), THAP domain containing
apoptosis associated protein 3 (THAP3), and calcium/calmodulin-
dependent protein kinase II delta (CAMK2D). Increased expres-
sion of glucose metabolic enzymes, glucose phosphate isomerase
(GPI ), and UDP-glucose pyrophosphorylase 2 (UGP2) was also
evident in LRECe vs. LRECb. KEGG pathway analysis (DAVID)
revealed up-regulation of the Notch pathway in LRECb (DVL2
an inhibitor of the pathway is down-regulated, CAMK2D and
MAML3 are up-regulated).
The most significant network associated with genes that were
differentially expressed in LRECb vs. LRECe was related to tis-
sue development, cell growth, and proliferation (Figure 4A, IPA
score= 43). This network showed up-regulation in LRECb of
HIP1, which may be required for differentiation or survival of
somatic progenitors, and TRIB2, which modulates signal trans-
duction pathways and may promote growth of mouse myeloid
progenitors. This was followed by a network associated with tis-
sue injury (Figure 4B, IPA score= 34), featuring up-regulation of
a heat shock protein module in LRECb. The top three canoni-
cal pathways identified by IPA for genes that were preferentially
expressed by LRECb (LRECb vs. LRECe) pertained to: the mitotic
roles of polo-like kinases, cleavage, and polyadenylation of pre-
mRNA, and chemokine signaling. Because polo-like kinases are
key centrosome regulators and asymmetric localization of polo-
kinase promotes asymmetric division of adult stem cells (Rusan
and Peifer, 2007), the polo-like kinase pathway may be particularly
noteworthy.
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Table 1 | Attributes of LREC in prepubertal bovine mammary epithelium1 .
Gene LRECb LRECe Description
STEMNESS MARKERS
Transcription Factors
NR5A2 Pluripotency transcription factor can substitute for OCT4 in production of induced pluripotent stem cells (iPSC)
2.5  2.3 
HNF4A Liver stem cell transcription factor
2.0  1.2 
SOX15 Encodes a member of the SOX (SRY-related HMG-box) family of transcription factors involved in the regulation
of embryonic development and in the determination of the cell fate
2.4  1.3 
ESR1 LRECb are ESR1-negative (immunohistochemistry) and express low levels of ESR1 transcripts. ESR1 is a
negative marker for MaSC in mouse and human. LRECe are ESR1-positive or negative
-3.6  1.3 
Nuclear complex, pore, or transport
NUP153 Nuclear basket protein, can cause chromatin modification, may be marker of proliferation, nuclear pore complex
proteins are often down-regulated in differentiated cells
7.1 -1.3 
IP013 Nucleocytoplasmic transport protein, importin 13, may serve as a marker for corneal stem and progenitor cells,
nuclear transport plays a key role in stem cell lineage determination
2.4  2.0 
TERF1 Telomeric repeat binding factor 1, marker for human and mouse embryonic stem cells
3.7  1.0 
Cytoskeleton or membrane associated
THY1 THY1/CD90 is up-regulated in MaSC enriched human mammary epithelial cultures [Expression of THY1 in
LRECb did not differ from that in ECb, but was 5.6-fold greater than that in LRECe]
2.9  -2.3 
HIP1 May be required for differentiation or survival of somatic progenitors [Expression of HIP1 in LRECb did not differ
from that in ECb, but was 3.1-fold greater than that in LRECe]
2.6  -1.3 
NES Intermediate filament protein, expressed in stem cells: neural and hair follicle. [Expression of NES in LRECb did
not differ from that in ECe, but was 2.6-fold greater than that in LRECe]
-3.6 -1.3 
FNDC3B Regulator of adipogenesis and cell proliferation, adhesion, spreading, and migration
2.9   2.1 
Enzyme or Kinase
ALDH3B1 Proposed MaSC marker
2.0  1.3  
TRIB2 Modulates signal transduction pathways and may promote growth of mouse myeloid progenitors. [Expression
of TRIB2 in LRECb did not differ from that in ECb, but was 6.7-fold greater than that in LRECe]
1.3  1.5 
Asymmetric cell renewal
EPHX1, MTBP,
COL11A1
Among proposed markers for somatic stem cells, based on genes that are tightly coupled to asymmetric
self-renewal in vitro (Noh et al., 2011)
2.3  1.0 
ARHGAP
6.3   1.6 
(Continued)
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Table 1 | Continued
Gene LRECb LRECe Description
DIFFERENTIATION MARKERS
Transcript Factor
XIST No to little expression of X-chromosome inactivation factor in LRECb, absence or low expression has been
associated with hematopoietic stem and progenitor cells, respectively
-17.1  10.4  
SIX2 Down-regulated in LRECb, is a homeobox protein, transcription factor. Like other members of this family, it may
be involved in differentiation, involved in limb or eye development
-3.2  -1.1  
PAX6 Down-regulated in LRECb, is a paired box protein transcription factor. Implicated role in organogenesis. Possible
role of PAX6 in breast cancer and tumorigenesis has recently been identified
-2.7   2.0 
Intermediate Filaments
KRT5 Cytokeratin 5 transcripts are down-regulated in LRECb, consistent with KRT5-negative MaSC in mouse and
human
-4.7  -2.3 
KRT19 The basal epithelium is typically KRT 19 negative, consistent with KRT19-negative MaSC in mouse and human.
[Expression based on quantitative immunohistochemistry]
-2.4  1.1  
1The transcript abundance in LRECb and LRECe are expressed relative to that in respective control cells. Abundance that varies significantly in LREC and control cells
is depicted graphically, with the fold change provided below the graphic. Fold change is provided even for those genes whose abundance did not differ between the
LREC class and its control cells (designated by open bar).
Transcripts were up-regulated greater than threefold change relative to respective control.
Transcripts were up-regulated greater than two but less than threefold change relative to respective control.
Transcripts were down-regulated greater than twofold change relative to respective control.
Transcripts abundance did not differ from respective control.
TRANSCRIPTOMES OF ECb VS. ECe
Epithelial cells isolated from basal and embedded layers exhibited
transcriptome profiles that were consistent with their location.
Analysis identified 317 genes that were differentially expressed
(Table S1 in Supplementary Material), 263 of which were func-
tionally annotated. Among these, ECb expressed increased tran-
script levels for cell structural and motility genes, including
actin (ACTA2), myosin (MYH8, MYO6, MRCL3), SPTBN1 (actin
cross linking scaffold protein), and TSPAN31. Transcripts for
JAG-1 (ligand of Notch pathway) and FST like 1 (FSTL1)
were enriched in basal epithelium. The enriched expression
of integrin-β1 (ITGB1) within ECb was consistent with its
use as a marker to isolate MaSC (Shackleton et al., 2006),
most likely to enrich the sorted population for basal epithelial
cells. Additionally, a number of heat shock proteins (HSPA8,
HSPA4, HSP90AB1), peptidases (USP4, USP16, USP25, PSMD14,
MME), ribosomal proteins, translational regulators, components
of the ECM and its regulators (collagens, MFAP5, FBN1, FSTL1,
CHAD, ERBB2IP, SPARC), and tumor suppressors [MYCBP2, and
MTSS1 (LOC788499)] were also up-regulated in ECb. However,
transcripts of membrane transporters (AP1M1, APOE, AQP7,
SLC13A3, SLC38A3,TMED3,CLCN3) were more highly expressed
in ECe than ECb. Thus, control cells harvested from basal and
from embedded layers within the mammary epithelium possess
different characteristics and appear to represent two distinct cell
populations.
To better understand key biological processes occurring in basal
and embedded epithelium, we utilized Ingenuity Pathway Analy-
sis to generate gene networks and canonical pathways for genes
that are differentially expressed between ECb and ECe. All iden-
tified networks (networks of endocrine system development and
function, cancer, cell cycle, tissue development) were highly sig-
nificant as measured by IPA score (ranges from 35 to 42). The
identified network for endocrine development and function, lipid
metabolism (Figure 5A) features an estrogen signaling module,
peptidase, Ubiquitination, and ubiquitin modules. The identified
network for cancer (Figure 5B) contains two heat shock protein
modules. The canonical pathways identified by IPA analysis were
protein ubiquitination, hypoxia signaling, and clathrin mediated
endocytosis. Extrinsic growth factors and regulators, and hypoxia
inducing factor have been identified as molecules prevalent in the
stem cell niche (Li and Xie, 2005; Mazumdar et al., 2010), tran-
scripts for these molecules are expressed in the basal epithelium
(Table 2; Figure 6).
IMMUNOHISTOCHEMICAL AND REALTIME RT-PCR EVALUATION OF
POTENTIAL NOVEL LRECb AND LRECe MARKERS
Genes that are highly expressed in LRECb and LRECe may pro-
vide novel markers for MaSC and progenitor cells. Those that
were evaluated by immunohistochemistry were: NR5A2,NUP153,
FNDC3B, and HNF4A. NR5A2 is a pluripotency gene that aids in
inducing somatic cells into pluripotency (iPSC; Heng et al., 2010).
Frontiers in Oncology | Cancer Genetics February 2013 | Volume 3 | Article 21 | 8
Choudhary et al. LREC and mammary progenitors
Table 2 | Pathways in LREC and microenvironment of the basal
mammary epithelium.
PATHWAY INVOLVEMENT WITH LREC
Notch pathway Up-regulation of Notch pathway in LRECb.
Involvement of Notch pathway in LRECb along with
pathways promoting expansion of MaSC is consistent
with the need for balanced expansion of both MaSC
and progenitor cell populations. Both populations
must expand during ductal elongation
TGF-β signaling Up-regulation in LRECb of components of TGF-β
pathway associated with stem cell renewal
MAPK pathway Up-regulation in LRECb, pathway involved in cell
growth and proliferation
WNT pathway Involvement of WNT pathway. Up-regulation of many
components in LRECb. Presumed activity in
LRECe>LRECb
MICROENVIRONMENT OF BASAL MAMMARY EPITHELIUM
LRECb Fibroblast growth factors (FGF2, FGF10), insulin-like
growth factor-2 (IGF2), follistatin (FST ), cytokines
(IL33, CSF3), Wnt chaperone (MESDC2), heat
inducible factors (HIF1A, HSP )
ECb Production of factors by ECb that may impact LRECb:
JAG-1 (a ligand of Notch pathway) fibroblast growth
factors (FGF1, FGF2, FGF10), insulin-like factor-2
(IGF2), follistatin like 1 (FSTL1), extracellular matrix
and its regulators (collagens, ITGB1, MFAP5, FBN1,
FSTL1, CHAD, ERBB2IP, SPARC ), and tumor
suppressors (MTSS1, Myc binding proteins)
Stromal cells Gene expression by stromal cells was not assessed.
However, these cells also contribute to the
microenvironment of the basal epithelium
NUP153 is a nuclear basket protein that can cause chromatin
modification (Vaquerizas et al., 2010), and FNDC3B is a regu-
lator of adipogenesis and cell proliferation, adhesion, spreading,
and migration (Nishizuka et al., 2009). HNF4A may serve as a
stem cell regulator (Battle et al., 2006; Koh et al., 2010; Delaforest
et al., 2011) and was identified as a key pathway component by IPA
analysis of expression data for LRECb and LRECe. Transcripts for
NR5A2, NUP153, FNDC3B, and HNF4A were more abundant in
LRECb than in control cells, with a general expression pattern of
LRECb> LRECe> EC).
Immunohistochemical analysis showed that 1–6% of epithe-
lial cells expressed these potential markers. In agreement with
transcript abundance, positive cells in the basal epithelium were
more intensely stained than those in suprabasal locations. The
abundance and localization of NR5A2, NUP153, FNDC3B, and
HNF4A-positive cells (Figures 7A–D) were similar to that of
LRECs. Co-localization studies showed that LREC expressed these
markers. Surprisingly, expression of FNDC3B was not limited to
the cytoplasmic compartment of the cell. Expression of FNDC3B
was found to be cytoplasmic (arrows) and nuclear (arrowheads)
and co-expressed with BrdU in approximately half of the LRECb
(Figure 7G), which is consistent with its possible utility as a
marker for putative MaSC/progenitor cells. Co-localization stud-
ies also confirmed our previous finding (Capuco, 2007; Capuco
et al., 2009) that LRECb are ESR1-negative and LRECe are com-
posed of populations of ESR1-negative and ESR1-positive cells
(Figures 7E,F). Because of their potential utility for cell sorting,
we also identified transcripts that encoded surface proteins and
were up-regulated in LRECb (SAT2, CXCR4, SDPR, RTP3, CASR,
GNB4, and DRD2); however, we have not evaluated the suitability
of these membrane markers. Preliminary immunohistochemistry
results showed that CXCR4 and CASR are expressed by a small
number of epithelial cells.
Realtime RT-PCR was employed to confirm microarray results
for expression of transcripts for novel LREC-derived markers
(NR5A2, NUP153, FNDC3B) and the differentiation factor XIST
at the transcriptome level. Patterns of expression were very sim-
ilar for RT-PCR and microarray analysis (Figures 8A–C). Both
analyses showed that expression of the potential MaSC/progenitor
cell markers was increased in LRECb and, with the exception
of NUP153, in LRECe vs. their respective controls. Expression
of these markers was greater in LRECb vs. LRECe by microar-
ray analysis, but NR5A2 expression was not greater in LRECb
vs. LRECe when assessed by realtime RT-PCR. Consistent with
the undifferentiated state of putative MaSC, there was little to no
expression of the differentiation factor XIST in LRECb, and there
was lower expression of XIST in LRECb than in LRECe by both
methodologies. Expression of XIST non-coding RNA was less in
LRECe than in control cells as assessed by RT-PCR, but greater
when assessed by microarray hybridization. Overall, the utility of
microarray data for detecting LREC-derived markers for putative
MaSC/progenitor cells was supported by realtime RT-PCR and by
immunohistochemistry.
DISCUSSION
In this study, we employed the long-term retention of BrdU-
labeled DNA to identify putative MaSC/progenitor cells during
the period of ductal morphogenesis in the prepubertal mammary
gland. However, it must be understood that retention of labeled
DNA represents an integration of a cell’s past proliferation and
differentiation events and may not reflect that cell’s current status.
This is particularly relevant when assessing individual cells within a
population, e.g., expression of lineage markers by LREC. Nonethe-
less, we hypothesized that LREC are enriched for MaSC/progenitor
cells. In particular, we hypothesized that LRECb are enriched for
MaSC and LRECe are enriched for progenitor cells.
When comparing gene expression in LREC and control cells
it is important to consider the proliferative status of these cells.
A difference in the proliferative status of the two populations
may impose differences in gene expression between the popu-
lations that are reflective of their relative cell cycle activity rather
than cell lineage. To determine the extent to which LREC pro-
liferate during ductal morphogenesis in the prepubertal bovine
mammary gland, we evaluated expression of nuclear proliferation
antigens. In the present experiment, we found that approximately
13% of LREC and 15% of control cells in the present experiment
expressed PCNA (data not shown). In previous studies, we eval-
uated the Ki-67 labeling index in calves at an equivalent stage
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FIGURE 2 | Ingenuity Pathway Analysis (IPA) of genes differentially
expressed in LRECb vs. ECb. Genes that were differentially expressed in
LRECb vs. ECb were imported into IPA software, which revealed the
involvement of several networks pertinent to LRECb. Network (A) pertains
to cellular growth and proliferation and shows a single module with HNF4A
at its hub. Network (B) relates to cell cycle and post translational
modification. Red color denotes up-regulation in LRECb and green color
denotes down-regulation in LRECb relative to control cells. The IPA legend
is shown in Figure A1 in Appendix.
of mammary development to those in the present experiment
and reported that 5.4% of LREC expressed Ki-67 (Capuco, 2007)
and that 5–8% of total epithelial cells expressed Ki-67 (Capuco
et al., 2004). Thus, the proliferation status of LREC, control cells
FIGURE 3 | Ingenuity Pathway Analysis (IPA) of genes differentially
expressed in LRECe vs. ECe. Genes that were differentially expressed in
LRECe vs. ECe were imported into IPA software, which revealed the
involvement of several networks pertinent to LRECb. Network (A) relates
to cancer. Network (B) pertains to DNA replication, recombination and
repair and contains a HNF4A module. Red color denotes up-regulation in
LRECe and green color denotes down-regulation in LRECe relative to
control cells. The IPA legend is shown in Figure A1 in Appendix.
and the overall epithelial population appear to be similar and
not likely to unduly influence interpretation of gene expression
data.
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Table 3 |Top 10 up-regulated and down-regulated genes in LRECb vs. LRECe.
Gene symbol Bovine RefSeq ID Gene ID Gene annotation Fold change
UP-REGULATED IN LRECb
LOC786372 XM_001254067.2 297472984 PREDICTED: Bos taurus uncharacterized 14.3
RPS7 NM_001098874 402744265 Bos taurus ribosomal protein S7 12.5
CFL1 NM_001015655.1 62751776 Bos taurus cofilin 1 (non-muscle) 8.3
RRN3 NM_001192432 329112519 Bos taurus RRN3 RNA polymerase I transcription factor homolog (S.
cerevisiae)
7.1
COL1A2 NM_174520.2 31341767 Bos taurus collagen, type I, alpha 2 7.1
TRIB2 NM_178317.3 58332431 Bos taurus tribbles homolog 2 (Drosophila) 6.7
HSPB6 NM_001076027.1 115496723 Bos taurus heat shock protein, alpha-crystallin-related, B6 6.7
NUP153 NM_001205754 329664715 Bos taurus nucleoporin 153kDa 6.3
SLC10A5 XM_001253131.2 194672838 PREDICTED: Bos taurus similar to solute carrier family 10
(sodium/bile acid cotransporter family), member 5
5.9
RPL13 NM_001015543 402692502 Bos taurus ribosomal protein L13 5.9
DOWN-REGULATED IN LRECb
XIST NR_001464.2 166706871 Bos taurus X (inactive)-specific transcript, non-coding RNA −5.6
C19H17orf49 (BAP18) NM_001038092.1 84000150 Bos taurus chromosome 17 open reading frame 49 ortholog −3.9
SFRS5 NM_001098929.1 149643058 Bos taurus splicing factor, arginine/serine-rich 5 −3.7
THAP3 NM_001075347.1 115496479 Bos taurus THAP domain containing, apoptosis associated protein 3 −3.7
STK11IP XM_593410 358411062 PREDICTED: Bos taurus similar to LKB1 interacting protein −3.7
UGP2 NM_174212.2 110347575 Bos taurus UDP-glucose pyrophosphorylase 2 −3.4
SLC3A2 NM_001024488.2 164448599 Bos taurus solute carrier family 3 (activators of dibasic and neutral
amino acid transport), member 2
−3.3
CAMK2D NM_001046333.1 114052473 Bos taurus calcium/calmodulin-dependent protein kinase II delta −3.3
EIF4E3 NM_001102306.1 156121256 Bos taurus eukaryotic translation initiation factor 4E family member 3 −3.3
ATXN7L3B NM_001078161.2 210147444 Bos taurus ataxin 7-like 3B −3.0
To address our hypothesis that LRECb are enriched for MaSC
and that LRECe are enriched for more committed progenitors,
we performed transcriptome analyses on the four populations of
bovine mammary epithelial cells obtained by laser microdissection
of LREC and EC from basal and embedded layers of the epithe-
lium. Microarray analysis was used to reveal gene signatures for
the four categories of mammary epithelial cells: LRECb, LRECe,
ECb, and ECe.
The ECb and ECe were distinguishable by the increased abun-
dance, in basal cells, of transcripts for genes encoding structural
and motility proteins, extracellular growth factors, extracellu-
lar matrix (ECM) proteins, and ECM regulators. Additionally,
increased expression of transcripts for heat shock proteins, pepti-
dases, ribosomal proteins, ubiquitins, proteins that provide inter-
action between the cell and the ECM (caveolin-1, integrin-beta-1),
tumor suppressors, and epigenetic modifiers were also characteris-
tic of ECb. Myoepithelial cells, present in the basal layer of mature
mammary epithelium, may be a part of the stem cell niche and
their paracrine factors may regulate the proliferation, polarity, and
motility of mammary epithelial cells (Polyak and Hu, 2005). How-
ever, the precise nature of the ECb in a calf is uncertain. Expression
of markers for myoepithelial cells in mammary tissue from prepu-
bertal heifers is absent or expressed in a limited fashion (Capuco
et al., 2002; Ballagh et al., 2008; Ellis et al., 2012; Safayi et al., 2012).
Transcriptome analysis of LRECb vs. ECb showed that LRECb
possess characteristics consistent with those of MaSC (Tables 1
and 2). Our mRNA data indicated a reduced expression of ESR1
and increased expression of ALDH3B1 in LRECb vs. ECb, and
immunohistochemistry demonstrated a lack of detectable ESR1
protein in LRECb. Previous studies have demonstrated that mouse
(Sleeman et al., 2007) human (Anderson and Clarke, 2004) and
putative bovine MaSC are ESR1-negative (Capuco et al., 2009).
ALDH1 activity has been used as a stem and progenitor cell marker
in several tissues including blood, lung, prostate, pancreas, and
breast (Douville et al., 2009). However, 17 isoforms of ALDH have
been identified (Sladek, 2003) with different cellular and species
expression patterns (Hess et al., 2004). ALDH3B1 is expressed by
bovine LRECb. Increased abundance of HNF4A, NR5A2, TERF1,
THY1, NUP153, and FNDC3B mRNA and decreased abundance
XIST transcripts (non-coding) in LRECb are noteworthy. HNF4A
is a hepatic stem cell transcription factor whose associated network
was highly up-regulated in LRECb, suggesting a key role in these
cells. It is noteworthy that HNF4A has recently been implicated as
a regulator of mesenchymal stem cells (Koh et al., 2010). Lack of
expression or low expression of XIST has been associated with
stem and progenitor cells, respectively, in hematopoietic tissue
(Savarese et al., 2006). Subsequently, we evaluated four poten-
tially novel protein markers for stem/progenitor cells (NR5A2,
NUP153, FNDC3B, HNF4A) immunohistochemically and found
protein expression profiles that were consistent with the observed
transcript abundance in LRECb and LRECe. The number of cells
expressing these markers was limited and staining intensity of the
positive cells was greater for those located in the basal layer of the
epithelium.
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FIGURE 4 | Ingenuity Pathway Analysis (IPA) of genes differentially
expressed in LRECb vs. LRECe. Genes that were differentially expressed
in LRECb vs. LRECe were imported into IPA software, which revealed the
involvement of several networks pertinent to LRECb. Network (A) pertains
to tissue development, cell growth and proliferation. Network (B) is
associated with tissue injury and contains a heat shock protein module that
was up-regulated in LRECb. Red color denotes up-regulation in LRECb and
green color denotes down-regulation in LRECb relative to control cells. The
IPA legend is shown in Figure A1 in Appendix.
Because of their potential utility for cell sorting, we identified
transcripts that encoded surface proteins and were up-regulated
in LRECb. Among the cell surface markers, THY1/CD90 is a pro-
posed marker for mesenchymal, liver, keratinocyte, endometrial,
and hematopoietic stem cells. TRIB2 is an oncogene shown to
prolong growth of mouse myeloid progenitors (Keeshan et al.,
FIGURE 5 | Ingenuity Pathway Analysis (IPA) of genes differentially
expressed in ECb vs. ECe. Genes that were differentially expressed in ECb
vs. ECe were imported into IPA software, which revealed the involvement
of several networks pertinent to ECb. Network (A) pertains to endocrine
development and function, lipid metabolism. Network (B) is associated with
cancer and contains two heat shock protein modules. Red color denotes
up-regulation in LRECb and green color denotes down-regulation in LRECb
relative to control cells. The IPA legend is shown in Figure A1 in Appendix.
2006). SAT2 is the target of DNA methyltransferase 1 (DNMT1)
and an epigenetic modifier, whose methylation status may serve
as a marker for cancer prognosis (Jackson et al., 2004). CXCR4
is a receptor for the chemokine, stromal derived factor 1 (SDF-
1; Kang et al., 2005). SDF-1 is positively regulated by HIF1A,
linking the SDF-CXCR4 axis to hypoxic stress. G-protein signaling
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FIGURE 6 | Characteristics of putative MaSC (LRECb) and progenitor
cells (LRECe). Putative MaSC (LRECb) are localized in the basal epithelium in
a stem cell niche characterized as hypoxic but an environment enriched for
extracellular growth factors, tumor suppressors for regulating MaSC function.
LRECb exhibit enriched expressions of adhesion molecules and a variety of
potential MaSC biomarkers including HNF4A and the pluripotency marker,
NR5A2. Putative progenitor cells (LRECe) also express NR5A2 but at a
reduced level along with increased expression of differentiation factors
including XIST. Key features of control cells (non-LREC) in the basal and
embedded epithelial layers are also depicted.
proteins such as RGS4, which was up-regulated in LRECb, are
negative regulators of the SDF-CXCR4 axis. The pertinence of the
SDF-CXCR4 axis to stem cell regulation is the likelihood that mild
hypoxic stress induces expansion of the MaSC population analo-
gous to the expansion of breast cancer stem cells (Conley et al.,
2012).
Up-regulation of growth factors such as fibroblast growth
factors (FGF1, FGF2, FGF10), insulin-like factor-2 (IGF2), FST,
laminin (LAMC2), platelet-derived growth factor beta (PDGFB),
and plasminogen activator tissue (PLAT) in the basal epithelial
layer is consistent with the possible function of these molecules
as regulators of MaSC. The role of FGFs in mammary gland
development and growth has been demonstrated (Mailleux et al.,
2002; Sinowatz et al., 2006). Although our data do not provide
evidence for enhanced expression of receptors for these growth
factors in LRECb, transcripts for many of these receptors were
evident.
Further evidence in support of LRECb being a population of
cells that is enriched for MaSC comes from biological pathway
analysis of differentially expressed genes. A number of differen-
tially expressed genes (LRECb vs. ECb) were involved in MAPK,
WNT, and TGF-β pathways. The MAPK pathway regulates cel-
lular growth and proliferation. WNT and TGF-β pathways are
both involved in mammary stem cell renewal. Down-regulation of
TGF-β leads to a decline in MaSC number (Petersen and Polyak,
2010). A theme emerging from a variety of data is that stem
cells exhibit characteristics of cells under stress (Covello et al.,
2006; Mazumdar et al., 2010). An up-regulation of chaperones,
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FIGURE 7 | Immunohistochemical localization of potential mammary
stem/progenitor cell markers. (A–D) Consistent with transcriptome data,
cells that were positive for these novel markers were more strongly labeled
(brown nuclei) in the basal layer of mammary epithelium than in the
embedded layers. Solid arrows designate labeled nuclei of basal cells and
arrow heads designate labeled nuclei of embedded epithelial cells. NR5A2
(A), NUP153 (B), FNDC3B (C), HNF4A (D). (E,F) Immunofluorescent
micrograph demonstrating the ESR1 status of LREC. LRECb were
ESR1-negative and LRECe were a mixed population of ESR1-negative and
ESR1-positive cells. (G) Co-localization of FNDC3B (purple) and BrdU.
FNDC3B was expressed in the nucleus (arrow) and cytoplasm (arrowhead) of
LRECb (brown). Scale bar, 10µm.
ubiquitin/proteasome, DNA repair, and chromatin remodeling in
LRECb are consistent with this characteristic and support our
hypothesis that LRECb are enriched for MaSC.
Comparison of the transcript profiles of LRECe with those of
ECe and LRECb supports classification of LRECe as progenitor
cells. As with LRECb, presence of an HNF4A network and BrdU
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FIGURE 8 | Quantitative RT-PCR and microarray analysis of selected
genes. Concordance of gene expression patterns between microarray and
qRT-PCR for key genes. (A) LRECb vs. ECb; (B) LRECe vs. ECe; (C) LRECb
vs. LRECe. Data are expressed as fold change (log10) relative to indicated
comparisons.
label retaining ability suggest that LRECe possess some stem cell
attributes. However, up-regulation of metabolic enzymes and dif-
ferentiation factors suggest that LRECe are more differentiated
than LRECb.XIST is a non-coding RNA that inactivates one of the
X-chromosomes in the early embryo and initiates gene repression
and defines epigenetic transitions during development. Pluripo-
tency genes (NANOG,OCT4 and SOX2) cooperate to repressXIST
(Navarro et al., 2008). Our mRNA data revealed low expression
of XIST in LRECb and greater expression in LRECe and ECb,
consistent with classification of LRECb as MaSC and LRECe as
progenitor cells (Savarese et al., 2006). Finally, comparison of tran-
script abundance in LRECb vs. LRECe suggested up-regulation of
the Notch pathway in LRECb, implying increased transduction of
Table 4 | Attributes of murine somatic stem cells and bovine
mammary LREC1.
Murine somatic cells LRECb LRECe
GEP, SiEP
Wnt/β-catenin signaling +
PI3K/AKT signaling
TGF ßsignaling + +
IGF-1 signaling IGF2
JAK/Stat regulation
Cell Cycle (G1/S) Checkpoint +
NFκB signaling + +
GEP, HSCs, NSCs, ESCs
Wnt/β-catenin signaling +
PI3K/AKT signaling
Interferon signaling +
PDGF signaling
T cell receptor signaling
Estrogen receptor signaling + +
GEPs, SiEPs, HSCs, NSCs, ESCs
Chemokine signaling + +
Integrin signaling
SAPK/JNK signaling
VEGF signaling
IGF-1 signaling IGF2
B cell receptor signaling
SiEPs, HSCs, NSCs, ESCs
Wnt/β-catenin signaling
IL4 and IL6 signaling IL2, IL12
Alanine and aspartate metabolism
P38 MAPK signaling +
Integrin signaling
1Properties of murine somatic stem cells, assessed by Gordon and colleagues
(Giannakis et al., 2006), and the relevance of these properties to bovine mam-
mary LRECb. GEPs, gastric epithelial precursors; SiEPs, small intestine epithelial
precursors; HSCs, hematopoietic stem cells; NSCs, neural stem cells; ESCs,
embryonic stem cells.
Notch signals in LRECb. The Notch pathway plays a critical role
in cell fate determination of human mammary stem and prog-
enitor cells (Dontu et al., 2004). In murine mammary gland, the
Notch pathway constrains MaSC expansion and promotes pro-
liferation and commitment to the luminal lineage (Bouras et al.,
2008). Involvement of Notch signaling in putative MaSC (LRECb)
along with pathways regulating stem cell expansion is consistent
with the need to promote and balance the expansion of both MaSC
and luminal epithelial cells during ductal mammogenesis.
Using laser microdissection and RNA-sequencing, Gordon and
colleagues evaluated the transcriptomes of progenitor cells and
differentiated cells in the gastrointestinal tracts of mice, discerned
characteristics of these precursors and compared their molecu-
lar properties with those of stem/progenitor cells in other organs
(Stappenbeck et al., 2003; Giannakis et al., 2006). The use of laser
microdissection was efficacious and led to the identification of
characteristics that are shared among various stem cells. Many of
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the molecular features of gastrointestinal and other adult stem
cells that were identified are also evident in mammary LRECb
(Table 4), supporting the hypothesis that the LRECb population
is enriched for MaSC. Surprisingly, Gene Ontology-based analysis
of transcripts that are differentially enriched in LREC and EC were
inconsistent with the previously reported conclusion (Doherty
et al., 2008) that stem cells exhibit increased expression of genes
that are involved in nuclear function and RNA binding, while
differentiated cells are enriched for expression of genes that are
involved in extracellular space, signal transduction, and the plasma
membrane (data not shown).
Our study provides supportive evidence that the stem cell niche
lies in the basal layer of mammary epithelium. In this study,
LREC and control cells were isolated from known locations within
the mammary epithelium without previously destroying cellular
microenvironments. However, LRECb were probably not in direct
contact with the stroma, but were likely insulated by underly-
ing cytoplasmic extensions from surrounding cells. The dissected
LREC and control cells were adjacent or in close proximity to
allow evaluations of potential cross-talk between putative MaSC
and neighboring cells. Although potential signals were evident,
additional research is necessary to elucidate such cross-talk. Fur-
thermore, this analysis cannot account for signals that are derived
from adjacent stromal cells, which were not interrogated. Microar-
ray analyses of LRECb and LRECe identified features of LRECb
that are reflective of MaSC residing in their stem cell niche. Distinct
features of a stem cell niche, as discussed by Li and Xie (2005), are
the presence of (1) cell adhesion molecules that provide anchorage
for stem cells within the niche, (2) extrinsic factors within the niche
that regulate stem cell behavior, and (3) factors that cause asym-
metric cell division of the stem cell, that is upon cell division, one
daughter cell is maintained in the niche as a stem cell (self renewal)
and the other daughter cell leaves the niche to proliferate and
differentiate. Recent studies also indicated that a stem cell niche
elicits characteristics of hypoxic stress in stem cells, resulting in
the induction of proteins of the family of hypoxia inducible tran-
scription factors (HIF), such as HIF1A (up-regulated in LRECb),
and targets WNT, OCT4, IGF2 and Notch signaling molecules
(Kaufman, 2010; Mazumdar et al., 2010). Mild hypoxia appeared
to elicit expansion of mammary tumor stem cells via a mecha-
nism mediated by HIF1A (Conley et al., 2012). In our study, we
identified specific cell adhesion molecules, extrinsic growth fac-
tors and regulators, factors that promote asymmetric cell division,
and hypoxia inducing factor as molecules that are prevalent in the
stem cell niche of the basal epithelium (Table 1; Figure 6).
Finally, this research has identified molecular markers that
are enriched in LREC. Transcripts encoding the nuclear pro-
teins NR5A2, NUP153, FNDC3B, and HNF4A were identified as
potential markers for MaSC, as were transcripts encoding surface
proteins SAT2, THY1/CD90, CXCR4, SDPR, RTP3, CASR, GNB4,
and DRD2. To our knowledge, none of these proteins have been
tested or utilized as MaSC markers. Enrichment for MaSC has
been based upon sorting for multiple markers, as no single marker
has proved particularly efficacious. The utility of these markers for
identification and for sorting of MaSC remains to be evaluated.
CONCLUSION
Transcriptome analysis of LREC and mammary epithelial cell sub-
populations has provided a framework for future studies of normal
mammary epithelial cell development and homeostasis, and for
the pathobiology of breast cancer. First, our data support the
utility of long-term retention of DNA label as a means to iden-
tify an enriched population of progenitor cells. The data support
the hypothesis that LRECs are enriched for MaSC and progeni-
tor cells, with LRECb being enriched for progenitors with more
stemness features (putative MaSC) and LRECe being enriched for
more committed progenitors. Second, our data support the con-
tention that the basal layer of the mammary epithelium provides
for the MaSC niche. Lastly, we offer the first transcriptome profile
of putative MaSC (LRECb) and progenitor cells (LRECe) excised
from their in situ locations and we have identified potential novel
biomarkers for these cells.
Insights into the biology of stem cells will be gained by further
confirmation of candidate MaSC markers proposed by this study.
Such confirmation requires an evaluation of the self renewal and
differentiation potential of cells expressing these markers. Identifi-
cation of appropriate biomarkers will provide a means to identify
MaSC and will facilitate our understanding of MaSC functions
in mammary development, homeostasis, and cancer. Specific cell
surface markers will provide a means for future isolation of MaSC
and investigations of their biology.
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APPENDIX
FIGURE A1 | JPG file defining the symbols and relationships depicted in IPA networks.
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